Acadian Asset Management’s AYTU BioPharma AYTU Stock Holding History

Acadian Asset Management’s Portfolio AYTU Stock Details AYTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$27K	Hold	10,237	–	–	﹤0.01%	1921
2025 Q4	$26K	Hold	10,237	–	–	﹤0.01%	1879
2025 Q3	$19K	Hold	10,237	–	–	﹤0.01%	1771
2025 Q2	$22K	Sell	10,237 -4,385	-30%	-$6.81K	﹤0.01%	1576
2025 Q1	$17K	Hold	14,622	–	–	﹤0.01%	1538
2024 Q4	$24K	Hold	14,622	–	–	﹤0.01%	1529
2024 Q3	$34K	Hold	14,622	–	–	﹤0.01%	1900
2024 Q2	$41K	Hold	14,622	–	–	﹤0.01%	1622
2024 Q1	$44K	Hold	14,622	–	–	﹤0.01%	1396
2023 Q4	$41K	Sell	14,622 -7,915	-35%	-$21.8K	﹤0.01%	1480
2023 Q3	$59K	Hold	22,537	–	–	﹤0.01%	1405
2023 Q2	$35K	Hold	22,537	–	–	﹤0.01%	1569
2023 Q1	$50K	Buy	22,537 +2,640	+13%	+$7.72K	﹤0.01%	1514
2022 Q4	$75K	Buy	+19,897	New	+$74.9K	﹤0.01%	1492
2019 Q4	–	Sell	-243	Closed	-$58K	–	1881
2019 Q3	$58K	Buy	+243	New	+$73.2K	﹤0.01%	1583
2019 Q2	–	Sell	-216	Closed	-$72K	–	1792
2019 Q1	$72K	Buy	216 +143	+196%	+$35.6K	﹤0.01%	1599
2018 Q4	$11K	Hold	73	–	–	﹤0.01%	1601
2018 Q3	$40K	Buy	73 +27	+59%	+$25K	﹤0.01%	1412
2018 Q2	$48K	Buy	46 +43	+1,433%	+$71.7K	﹤0.01%	1394
2018 Q1	$7K	Buy	+3	New	+$20.6K	﹤0.01%	1577

Other funds holding AYTU

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CAM

Crown Advisors Management Larkspur, California $151M AUM 73.11% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PAP

Persistent Asset Partners Hong Kong $268M AUM 158.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acadian Asset Management's AYTU Position: Q1 2026 in Review

Acadian Asset Management held its AYTU BioPharma (AYTU) position steady in Q1 2026 at 10,237 shares worth $27K. The position accounts for ﹤0.01% of the portfolio, ranked #1921.

Acadian Asset Management first reported a position in AYTU in Q1 2018 and has held it in 20 quarters since. The position peaked at $75K in Q4 2022. 37 funds tracked by Wall St. Rank hold AYTU as of Q1 2026.

Acadian Asset Management held 10,237 shares of AYTU BioPharma worth $27K as of Q1 2026.
Acadian Asset Management left its AYTU BioPharma share count unchanged in Q1 2026.
AYTU BioPharma made up ﹤0.01% of Acadian Asset Management's portfolio in Q1 2026, its #1921 holding.
Acadian Asset Management first reported a position in AYTU BioPharma in Q1 2018 and has held it in 20 quarters since.
Acadian Asset Management's AYTU BioPharma position peaked at $75K in Q4 2022.
37 funds tracked by Wall St. Rank held AYTU BioPharma as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.